Preparing for Growth in Neurodegenerative Treatment Opportunities
How Clinical Teams Can Best Position Study Design and Strategy to Reach Study Participants
While patient enrollment and retention for clinical trials in this field can be challenging, CROs with the right expertise, tools and passion can help sponsors implement successful, cost-effective studies that minimize site and patient burden. This article covers:
- Current clinical research in neuroscience
- Complexity and challenges
- Protocol optimization at PPD
- PPD supporting neurodegenerative disease clinical trials
Input from Alberto Lledó, M.D., Ph.D., Christine Martino, John Hamlet, and Sabine Krofczik-Wilhelm, Ph.D., PPD, part of Thermo Fisher Scientific
Complete the form to read about growth in neurogenerative treatment and how PPD supports these clinical trials.